Clinical experience with novel K+ binders: what are the opportunities and challenges?
Topic:
Treatment
Speaker:
Professor C. Linde (Stockholm, SE)
Professor A. Stewart Coats (Sydney, AU)
Professor M. Volterrani (Rome, IT)
Sponsored by AstraZeneca
Event:
Heart Failure 2019
Congress Presentation
About the speakers
Professor Cecilia Linde
Karolinska Institute, Stockholm (Sweden)
63
presentations
5
followers
Professor Andrew Stewart Coats
Heart Research Institute, Sydney (Australia)
113
presentations
21
followers
Professor Maurizio Volterrani
San Raffaele Pisana Hospital IRCCS, Rome (Italy)
19
presentations
6
followers
4 more presentations in this session
Chair's introduction - The hyperkalaemia challenge in heart failure: what is the role of novel agents?
Speaker: Professor A. Stewart Coats (Sydney, AU)
Hyperkalaemia: a barrier to optimal management of patients with heart failure?
Speaker: Professor A. Stewart Coats (Sydney, AU)
Solving the K+ challenge in heart failure: are novel K+ binders the answer?
Speaker: Professor M. Volterrani (Rome, IT)
Access the full session
The hyperkalaemia challenge in heart failure: what is the role of novel agents?
Speakers:
Professor C. Linde, Professor A. Stewart Coats, Professor M. Volterrani, Professor A. Stewart Coats, Professor C. Linde...
About the event
ESC 365 is supported by
